Citations (75)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Jane Carlisle Maxwell. (2018) The Changing Face of Synthetic Cannabinoids in Texas. Journal of Psychoactive Drugs 50:4, pages 281-286.
Read now
Read now
Faith A. Ihongbe, Timothy O. Ihongbe, Saba W. Masho & Katerina Petrov. (2018) Association between synthetic cannabinoid use and depressive symptomology: Analysis of a US national survey of high-school seniors. Journal of Substance Use 23:2, pages 113-119.
Read now
Read now
Rachelle Abouchedid, Simon Hudson, Natalie Thurtle, Takahiro Yamamoto, James H. Ho, George Bailey, Michelle Wood, Nele Sadones, Christophe P. Stove, Alison Dines, John R. H. Archer, David M. Wood & Paul I. Dargan. (2017) Analytical confirmation of synthetic cannabinoids in a cohort of 179 presentations with acute recreational drug toxicity to an Emergency Department in London, UK in the first half of 2015 . Clinical Toxicology 55:5, pages 338-345.
Read now
Read now
Yoshito Kamijo, Michiko Takai, Yuji Fujita & Tetsuya Sakamoto. (2016) A multicenter retrospective survey of poisoning after consumption of products containing novel psychoactive substances from 2013 to 2014 in Japan. The American Journal of Drug and Alcohol Abuse 42:5, pages 513-519.
Read now
Read now
Robert J. Tait, David Caldicott, David Mountain, Simon L. Hill & Simon Lenton. (2016) A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. Clinical Toxicology 54:1, pages 1-13.
Read now
Read now
Peter B. Chase, Jeff Hawkins, Jarrod Mosier, Ernest Jimenez, Keith Boesen, Barry K. Logan & Frank G. Walter. (2016) Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs. Clinical Toxicology 54:1, pages 14-19.
Read now
Read now
Danièle Debruyne & Reynald Le Boisselier. (2015) Emerging drugs of abuse: current perspectives on synthetic cannabinoids. Substance Abuse and Rehabilitation 6, pages 113-129.
Read now
Read now
Andreja Celofiga, Jure Koprivsek & Janez Klavz. (2014) Use of Synthetic Cannabinoids in Patients With Psychotic Disorders: Case Series. Journal of Dual Diagnosis 10:3, pages 168-173.
Read now
Read now
D. M. Wood, F. Heyerdahl, C. B. Yates, A. M. Dines, I. Giraudon, K. E. Hovda & P. I. Dargan. (2014) The European Drug Emergencies Network (Euro-DEN). Clinical Toxicology 52:4, pages 239-241.
Read now
Read now
Articles from other publishers (66)
Alireza Amanollahi, Tannaz Babeveynezhad, Mohsen Sedighi, Shahin Shadnia, Sadaf Akbari, Mahbobeh Taheri, Mahboobeh Besharatpour, Goljamal Jorjani, Elham Salehian, Koorosh Etemad & Yadollah Mehrabi. (2023) Incidence of rhabdomyolysis occurrence in psychoactive substances intoxication: a systematic review and meta-analysis. Scientific Reports 13:1.
Crossref
Crossref
Arianna Giorgetti, Vasco Orazietti, Francesco Paolo Busardò & Raffaele Giorgetti. (2023) Psychomotor performances relevant for driving under the combined effect of ethanol and synthetic cannabinoids: A systematic review. Frontiers in Psychiatry 14.
Crossref
Crossref
Hugo López-Pelayo, Santiago Madero, Lies Gremeaux, Sanna Rönkä & João Matias. (2022) Synthetic Cannabinoids and Cannabis: How the Patterns of Use Differ: Results from the European Web Survey on Drugs. International Journal of Mental Health and Addiction.
Crossref
Crossref
Patrick Dahm, Andreas Thomas, Markus A. Rothschild, Mario Thevis & Katja Mercer-Chalmers-Bender. (2021) Phase I-metabolism studies of the synthetic cannabinoids PX-1 and PX-2 using three different in vitro models. Forensic Toxicology 40:2, pages 244-262.
Crossref
Crossref
Martin F. Casey & Alex F. Manini. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
415
446
.
Liana Fattore, Matteo Marti, Rafaela Mostallino & Maria Paola Castelli. (2020) Sex and Gender Differences in the Effects of Novel Psychoactive Substances. Brain Sciences 10:9, pages 606.
Crossref
Crossref
Dino Luethi & Matthias E. Liechti. (2020) Designer drugs: mechanism of action and adverse effects. Archives of Toxicology 94:4, pages 1085-1133.
Crossref
Crossref
Armağan ARAL, Bahattin AVCI & Miraç Barış USTA. (2020) Sentetik Kannabinoidlerin Nöropsikiyatrik Etkileri. Arşiv Kaynak Tarama Dergisi 29:1, pages 29-36.
Crossref
Crossref
Sharon R. Sznitman, Lianna Pinsky-Talbi, Maisar Salameh, Taleb Moed & Yedidia Bentur. (2020) Cannabis and synthetic cannabinoid exposure reported to the Israel poison information center: Examining differences in exposures to medical and recreational compounds. International Journal of Drug Policy 77, pages 102711.
Crossref
Crossref
Zsuzsa Kaló, Szilvia Kassai, József Rácz & Marie Claire Van Hout. (2018) Synthetic Cannabinoids (SCs) in Metaphors: a Metaphorical Analysis of User Experiences of Synthetic Cannabinoids in Two Countries. International Journal of Mental Health and Addiction 18:1, pages 160-176.
Crossref
Crossref
Fiona Hutton. 2020. Cultures of Intoxication. Cultures of Intoxication
87
110
.
Laura Orsolini, Stefania Chiappini, Duccio Papanti, Domenico De Berardis, John M. Corkery & Fabrizio Schifano. (2019) The Bridge Between Classical and “Synthetic”/Chemical Psychoses: Towards a Clinical, Psychopathological, and Therapeutic Perspective. Frontiers in Psychiatry 10.
Crossref
Crossref
Luke J. Ney, Allison Matthews, Raimondo Bruno & Kim L. Felmingham. (2019) Cannabinoid interventions for PTSD: Where to next?. Progress in Neuro-Psychopharmacology and Biological Psychiatry 93, pages 124-140.
Crossref
Crossref
Hina Akram, Claire Mokrysz & H Valerie Curran. (2019) What are the psychological effects of using synthetic cannabinoids? A systematic review. Journal of Psychopharmacology 33:3, pages 271-283.
Crossref
Crossref
Ahmet Kırgız & Havva Kaldırım. (2017) Bilateral multiple exudative retinal detachments and macular edema in a patient diagnosed with synthetic cannabinoid (Bonzai) intoxication. International Ophthalmology 39:1, pages 237-241.
Crossref
Crossref
Sai Krishna Tikka & Deepak Cyril D’Souza. 2019. Cannabis Use Disorders. Cannabis Use Disorders
127
155
.
Payal Sud, Miles Gordon, Laura Tortora, Matthew Stripp, Damon Borg & Adam Berman. (2018) Retrospective Chart Review of Synthetic Cannabinoid Intoxication with Toxicologic Analysis. Western Journal of Emergency Medicine 19:3, pages 567-572.
Crossref
Crossref
Halil Kara. (2017) Abuse of Cannabinoids. Ankara Medical Journal.
Crossref
Crossref
Brandon J. Warrick, Anita Paula Tataru & Roy Gerona. (2017) New Psychoactive Substances in Pediatric Patients. Pediatric Clinics of North America 64:6, pages 1223-1241.
Crossref
Crossref
Zurina Hassan, Oliver G. Bosch, Darshan Singh, Suresh Narayanan, B. Vicknasingam Kasinather, Erich Seifritz, Johannes Kornhuber, Boris B. Quednow & Christian P. Müller. (2017) Novel Psychoactive Substances—Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs. Frontiers in Psychiatry 8.
Crossref
Crossref
Gary Sweet, Sara Kim, Samuel Martin, Nicole B. Washington & Nancy Brahm. (2017) Psychiatric symptoms and synthetic cannabinoid use: Information for clinicians. Mental Health Clinician 7:4, pages 156-159.
Crossref
Crossref
Sebastian Rojek, Małgorzata Kłys, Martyna Maciów-Głąb & Karol Kula. (2017) A new challenge in forensic toxicology exemplified by a case of murder under the influence of a synthetic cannabinoid – AM-2201. Legal Medicine 27, pages 25-31.
Crossref
Crossref
Noreen D Mdege, Nick Meader, Charlie Lloyd, Steve Parrott & Jim McCambridge. (2017) The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations. Public Health Research 5:4, pages 1-138.
Crossref
Crossref
Francois R. Lamy, Raminta Daniulaityte, Ramzi W. Nahhas, Monica J. Barratt, Alan G. Smith, Amit Sheth, Silvia S. Martins, Edward W. Boyer & Robert G. Carlson. (2017) Increases in synthetic cannabinoids-related harms: Results from a longitudinal web-based content analysis. International Journal of Drug Policy 44, pages 121-129.
Crossref
Crossref
Emilie Jouanjus, Valentin Raymond, Maryse Lapeyre-Mestre & Valérie Wolff. (2017) What is the Current Knowledge About the Cardiovascular Risk for Users of Cannabis-Based Products? A Systematic Review. Current Atherosclerosis Reports 19:6.
Crossref
Crossref
Marie Claire Van Hout & Evelyn Hearne. (2016) User Experiences of Development of Dependence on the Synthetic Cannabinoids, 5f-AKB48 and 5F-PB-22, and Subsequent Withdrawal Syndromes. International Journal of Mental Health and Addiction 15:3, pages 565-579.
Crossref
Crossref
Bryan Lee Miller, John M. Stogner, J. Mitchell Miller & M. Isabel Fernandez. (2016) The Arrest and Synthetic Novel Psychoactive Drug Relationship. Journal of Drug Issues 47:1, pages 91-103.
Crossref
Crossref
S.S. Tuv, V. Auwärter & V. Vindenes. 2017. Handbook of Cannabis and Related Pathologies. Handbook of Cannabis and Related Pathologies
848
855
.
Joseph B. Richardson, Christopher St. Vil, Eric Wish & Carnell Cooper. (2016) “On papers”: perceptions of synthetic cannabinoid use among black males under criminal justice supervision. Health & Justice 4:1.
Crossref
Crossref
Hélène Peyrière, Céline Eiden, Michel Mallaret & Caroline Victorri-Vigneau. (2016) Medical complications of psychoactive substances with abuse risks: Detection and assessment by the network of French addictovigilance centres. Therapies 71:6, pages 563-573.
Crossref
Crossref
David M. Wood & Paul I. Dargan. 2016. Current Practice in Forensic Medicine. Current Practice in Forensic Medicine
35
46
.
Helge H. Müller, Johannes Kornhuber & Wolfgang Sperling. (2016) The behavioral profile of spice and synthetic cannabinoids in humans. Brain Research Bulletin 126, pages 3-7.
Crossref
Crossref
Wojciech Kolodziejczyk, Supratik Kar, Glake A. Hill & Jerzy Leszczynski. (2016) A comprehensive computational analysis of cathinone and its metabolites using quantum mechanical approaches and docking studies. Structural Chemistry 27:4, pages 1291-1302.
Crossref
Crossref
Daniel Castellanos. (2016) Synthetic cannabinoids 2015: An update for pediatricians in clinical practice. World Journal of Clinical Pediatrics 5:1, pages 16.
Crossref
Crossref
Adebisi I. Obafemi, Kurt Kleinschmidt, Collin Goto & Drew Fout. (2015) Cluster of Acute Toxicity from Ingestion of Synthetic Cannabinoid-Laced Brownies. Journal of Medical Toxicology 11:4, pages 426-429.
Crossref
Crossref
Niels Bjerre Holm, Line Marie Nielsen & Kristian Linnet. (2015) CYP3A4 Mediates Oxidative Metabolism of the Synthetic Cannabinoid AKB-48. The AAPS Journal 17:5, pages 1237-1245.
Crossref
Crossref
Deborah A. Salani & Martin M. Zdanowicz. (2015) Synthetic Cannabinoids: The Dangers of Spicing It Up. Journal of Psychosocial Nursing and Mental Health Services 53:5, pages 36-43.
Crossref
Crossref
Jan van Amsterdam, Tibor Brunt & Wim van den Brink. (2015) The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects. Journal of Psychopharmacology 29:3, pages 254-263.
Crossref
Crossref
Anne-Laure Pélissier-Alicot. (2015) Les cannabinoïdes de synthèse : épidémiologie, modalités de consommations et effets cliniques. Toxicologie Analytique et Clinique 27:1, pages 33-40.
Crossref
Crossref
Niels Bjerre Holm, Anders Just Pedersen, Petur Weihe Dalsgaard & Kristian Linnet. (2015) Metabolites of 5F-AKB-48, a synthetic cannabinoid receptor agonist, identified in human urine and liver microsomal preparations using liquid chromatography high-resolution mass spectrometry. Drug Testing and Analysis 7:3, pages 199-206.
Crossref
Crossref
Brian P. Kersten & Megan E. McLaughlin. (2014) Toxicology and Management of Novel Psychoactive Drugs. Journal of Pharmacy Practice 28:1, pages 50-65.
Crossref
Crossref
Magdy A. Kharoshah, Mohammed Saleh Madadin, Sherien Salah Ghaleb, Hanan Hosny Hassan, Kholoud Samy Alsowayigh & Ritesh George Menezes. 2015. Heart and Toxins. Heart and Toxins
571
594
.
William D. Wessinger, Jeffery H. Moran & Kathryn A. Seely. 2015. Cannabinoid Modulation of Emotion, Memory, and Motivation. Cannabinoid Modulation of Emotion, Memory, and Motivation
205
224
.
Nathalie J. Jaenicke, Werner Pogoda, Alexander Paulke, Cora Wunder & Stefan W. Toennes. (2014) Retrospective analysis of synthetic cannabinoids in serum samples – epidemiology and consumption patterns. Forensic Science International 242, pages 81-87.
Crossref
Crossref
Denise Walker, Clayton Neighbors, Thomas Walton, Adam Pierce, Lyungai Mbilinyi, Debra Kaysen & Roger Roffman. (2014) Spicing up the military: Use and effects of synthetic cannabis in substance abusing army personnel. Addictive Behaviors 39:7, pages 1139-1144.
Crossref
Crossref
D. M. Wood, S. L. Hill, S. H. L. Thomas & P. I. Dargan. (2014) Using poisons information service data to assess the acute harms associated with novel psychoactive substances. Drug Testing and Analysis 6:7-8, pages 850-860.
Crossref
Crossref
Christophe Soussan & Anette Kjellgren. (2017) The Flip Side of “Spice”: The Adverse Effects of Synthetic Cannabinoids as Discussed on a Swedish Internet Forum. Nordic Studies on Alcohol and Drugs 31:2, pages 207-220.
Crossref
Crossref
Tracy L. Brewer & Margie Collins. (2014) A review of clinical manifestations in adolescent and young adults after use of synthetic cannabinoids. Journal for Specialists in Pediatric Nursing 19:2, pages 119-126.
Crossref
Crossref
Yoshito Kamijo, Michiko Takai, Yuji Fujita, Yasuo Hirose, Yasumasa Iwasaki, Satoshi Ishihara, Takashi Yokoyama, Keiichi Yagi & Tetsuya Sakamoto. (2014) A Multicenter Retrospective Survey of Poisoning after Consumption of Products Containing Synthetic Chemicals in Japan. Internal Medicine 53:21, pages 2439-2445.
Crossref
Crossref
Jane Carlisle Maxwell. (2014) Psychoactive substances—Some new, some old: A scan of the situation in the U.S.. Drug and Alcohol Dependence 134, pages 71-77.
Crossref
Crossref
Frank Musshoff, Burkhard Madea, Gerhard Kernbach-Wighton, Wolfgang Bicker, Stefan Kneisel, Melanie Hutter & Volker Auwärter. (2013) Driving under the influence of synthetic cannabinoids (“Spice”): a case series. International Journal of Legal Medicine 128:1, pages 59-64.
Crossref
Crossref
Stefan Kneisel, Jörg Teske & Volker Auwärter. (2014) Analysis of synthetic cannabinoids in abstinence control: long drug detection windows in serum and implications for practitioners. Drug Testing and Analysis 6:1-2, pages 135-136.
Crossref
Crossref
J. K. Yeakel & B. K. Logan. (2013) Blood Synthetic Cannabinoid Concentrations in Cases of Suspected Impaired Driving. Journal of Analytical Toxicology 37:8, pages 547-551.
Crossref
Crossref
Karen Miotto, Joan Striebel, Arthur K. Cho & Christine Wang. (2013) Clinical and pharmacological aspects of bath salt use: A review of the literature and case reports. Drug and Alcohol Dependence 132:1-2, pages 1-12.
Crossref
Crossref
Maren Hermanns-Clausen, Stefan Kneisel, Melanie Hutter, Bela Szabo & Volker Auwärter. (2013) Acute intoxication by synthetic cannabinoids - Four case reports. Drug Testing and Analysis 5:9-10, pages 790-794.
Crossref
Crossref
Max Spaderna, Peter H. Addy & Deepak Cyril D’Souza. (2013) Spicing things up: synthetic cannabinoids. Psychopharmacology 228:4, pages 525-540.
Crossref
Crossref
Adam R. Winstock & Monica J. Barratt. (2013) Synthetic cannabis: A comparison of patterns of use and effect profile with natural cannabis in a large global sample. Drug and Alcohol Dependence 131:1-2, pages 106-111.
Crossref
Crossref
Duccio Papanti, Fabrizio Schifano, Giulia Botteon, Francesca Bertossi, Jason Mannix, Daniela Vidoni, Matteo Impagnatiello, Elisabetta Pascolo‐Fabrici & Tommaso Bonavigo. (2013) “Spiceophrenia”: a systematic overview of “Spice”‐related psychopathological issues and a case report. Human Psychopharmacology: Clinical and Experimental 28:4, pages 379-389.
Crossref
Crossref
Adam R. Winstock & Monica J. Barratt. (2013) The 12‐month prevalence and nature of adverse experiences resulting in emergency medical presentations associated with the use of synthetic cannabinoid products. Human Psychopharmacology: Clinical and Experimental 28:4, pages 390-393.
Crossref
Crossref
Stefan Kneisel, Michael Speck, Bjoern Moosmann, Todd M. Corneillie, Nathaniel G. Butlin & Volker Auwärter. (2013) LC/ESI-MS/MS method for quantification of 28 synthetic cannabinoids in neat oral fluid and its application to preliminary studies on their detection windows. Analytical and Bioanalytical Chemistry 405:14, pages 4691-4706.
Crossref
Crossref
Anette KjellgrenHelena HenningssonChristophe Soussan. (2013) Fascination and Social Togetherness–-Discussions about Spice Smoking on a Swedish Internet Forum. Substance Abuse: Research and Treatment 7, pages SART.S13323.
Crossref
Crossref
Volker Auwärter, Paul I. Dargan & David M. Wood. 2013. Novel Psychoactive Substances. Novel Psychoactive Substances
317
343
.
Kathryn A. Seely, Jeff Lapoint, Jeffery H. Moran & Liana Fattore. (2012) Spice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoids. Progress in Neuro-Psychopharmacology and Biological Psychiatry 39:2, pages 234-243.
Crossref
Crossref
V. Auwärter, S. Kneisel, M. Hutter & A. Thierauf. (2012) Synthetische CannabinoideSynthetic cannabinoids. Rechtsmedizin 22:4, pages 259-271.
Crossref
Crossref
Megan Grabenauer, Wojciech L. Krol, Jenny L. Wiley & Brian F. Thomas. (2012) Analysis of Synthetic Cannabinoids Using High-Resolution Mass Spectrometry and Mass Defect Filtering: Implications for Nontargeted Screening of Designer Drugs. Analytical Chemistry 84:13, pages 5574-5581.
Crossref
Crossref
Johnnie Faircloth, Bharat Khandheria & Shu Shum. (2012) Case Report: Adverse Reaction to Synthetic Marijuana. The American Journal on Addictions 21:3, pages 289-290.
Crossref
Crossref